Two-way ANOVA indicated that the interactions between VSL#3 and hMSCs in inhibiting central and peripheral inflammation via downregulating the same NLRP3 inflammasome were beneficial to the prevention of dopaminergic neuron loss in PD mice. Here, NLRP3 is linked to Parkinson disease.